Accepting the universal truths of cervical human papillomavirus epidemiology in pursuit of the remaining mysteries

Sexually Transmitted Diseases

Volumn 38, Issue 10, 2011, Pages 907-908

  Schiffman, Mark ^a   Gage, Julia C ^a   Clarke, Megan A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CONDYLOMA ACUMINATUM; EDITORIAL; EPIDEMIC; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INCIDENCE; NONHUMAN; PREVALENCE; SEXUAL TRANSMISSION; SEXUALITY; UTERINE CERVIX; UTERINE CERVIX CANCER; WART VIRUS;

FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 80052980549     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318224a63f     Document Type: Editorial

References (15)

1. Sauvaget C, Nene BM, Jayant K, et al. Prevalence and determinants of high-risk human papillomavirus infection in middle-aged Indian women. Sex Transm Dis 2011; 38:902-906.
2. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360:1385-1394.
3. Veldhuijzen NJ, Snijders PJ, Reiss P, et al. Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis 2010; 10:862-874.
4. Plummer M, Herrero R, Franceschi S, et al. Smoking and cervical cancer: Pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control 2003; 14:805-814. (Pubitemid 37500732)
5. Moreno V, Bosch FX, Munoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentric case-control study. Lancet 2002; 359:1085-1092. (Pubitemid 34270731)
6. Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus in cervical cancer: The IARC multicentric casecontrol study. Lancet 2002; 359:1093-1101. (Pubitemid 34270732)
7. Appleby P, Beral V, Berrington de Gonzalez A, et al. Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006; 118:1481-1495.
8. Appleby P, Beral V, Berrington de Gonzalez A, et al. Cervical cancer and hormonal contraceptives: Collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007; 370:1609-1621.
9. Cervical carcinoma and reproductive factors: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 2006; 119:1108-1124.
10. Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 2003; 88:63-73.
11. de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 2010; 11:1048-1056.
12. Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: Addressing the limits of epidemiology at the borderline. Infect Agent Cancer 2009; 48.
13. Franceschi S, Herrero R, Clifford GM, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006; 119:2677-2684. (Pubitemid 44691325)
14. Pfeiffer RM, Wheeler WA, Mbisa G, et al. Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: Clues about etiology. Ann Epidemiol 2010; 20:958-963.
15. Winer RL, Hughes JP, Feng Q, et al. Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women. Cancer Epidemiol Biomarkers Prev 2011; 20:699-707.